Open Access
Open access
том 2015 страницы 1-11

Comprehensive Review on Betulin as a Potent Anticancer Agent

Тип публикацииJournal Article
Дата публикации2015-03-19
scimago Q2
wos Q3
SJR0.744
CiteScore7.9
Impact factor2.3
ISSN23146133, 23146141
General Biochemistry, Genetics and Molecular Biology
General Medicine
General Immunology and Microbiology
Краткое описание

Numerous plant-derived substances, and their derivatives, are effective antitumour and chemopreventive agents. Yet, there are also a plethora of tumour types that do not respond, or become resistant, to these natural substances. This requires the discovery of new active compounds. Betulin (BE) is a pentacyclic triterpene and secondary metabolite of plants abundantly found in the outer bark of the birch treeBetulaceaesp. BE displays a broad spectrum of biological and pharmacological properties, among which the anticancer and chemopreventive activity attract most of the attention. In this vein, BE and its natural and synthetic derivatives act specifically on cancer cells with low cytotoxicity towards normal cells. Although the antineoplastic mechanism of action of BE is not well understood yet, several interesting aspects of BE’s interactions are coming to light. This review will summarize the anticancer and chemopreventive potential of BEin vitroandin vivoby carefully dissecting and comparing the doses and tumour lines used in previous studies, as well as focusing on mechanisms underlying its activity at cellular and molecular level, and discuss future prospects.

Для доступа к списку цитирований публикации необходимо авторизоваться.
Для доступа к списку профилей, цитирующих публикацию, необходимо авторизоваться.

Топ-30

Журналы

2
4
6
8
10
12
14
Molecules
13 публикаций, 7.88%
International Journal of Molecular Sciences
5 публикаций, 3.03%
Cancers
4 публикации, 2.42%
Pharmaceuticals
4 публикации, 2.42%
Biomedicine and Pharmacotherapy
4 публикации, 2.42%
Khimiya Rastitel'nogo Syr'ya
4 публикации, 2.42%
Pharmaceutics
4 публикации, 2.42%
International Journal of Pharmaceutics
3 публикации, 1.82%
European Journal of Medicinal Chemistry
2 публикации, 1.21%
Russian Journal of Organic Chemistry
2 публикации, 1.21%
Journal of Natural Products
2 публикации, 1.21%
Anti-Cancer Agents in Medicinal Chemistry
2 публикации, 1.21%
Cancer Reports
2 публикации, 1.21%
Antibiotics
2 публикации, 1.21%
Reaction Kinetics, Mechanisms and Catalysis
2 публикации, 1.21%
Bioorganic and Medicinal Chemistry
2 публикации, 1.21%
Materials Today: Proceedings
2 публикации, 1.21%
MedComm
2 публикации, 1.21%
Russian Journal of Bioorganic Chemistry
2 публикации, 1.21%
bioRxiv
2 публикации, 1.21%
BMC Complementary Medicine and Therapies
2 публикации, 1.21%
ChemistrySelect
2 публикации, 1.21%
RSC Advances
2 публикации, 1.21%
Chemistry of Heterocyclic Compounds
1 публикация, 0.61%
Journal of Clinical Investigation
1 публикация, 0.61%
Current Drug Discovery Technologies
1 публикация, 0.61%
BIO Web of Conferences
1 публикация, 0.61%
Biological and Pharmaceutical Bulletin
1 публикация, 0.61%
Журнал органической химии
1 публикация, 0.61%
2
4
6
8
10
12
14

Издатели

5
10
15
20
25
30
35
40
45
MDPI
44 публикации, 26.67%
Elsevier
34 публикации, 20.61%
Springer Nature
25 публикаций, 15.15%
Wiley
11 публикаций, 6.67%
Pleiades Publishing
6 публикаций, 3.64%
American Chemical Society (ACS)
6 публикаций, 3.64%
Bentham Science Publishers Ltd.
6 публикаций, 3.64%
Royal Society of Chemistry (RSC)
5 публикаций, 3.03%
Frontiers Media S.A.
4 публикации, 2.42%
Altai State University
4 публикации, 2.42%
Oxford University Press
3 публикации, 1.82%
Hindawi Limited
2 публикации, 1.21%
openRxiv
2 публикации, 1.21%
American Society for Clinical Investigation
1 публикация, 0.61%
EDP Sciences
1 публикация, 0.61%
Pharmaceutical Society of Japan
1 публикация, 0.61%
Akademizdatcenter Nauka
1 публикация, 0.61%
SAGE
1 публикация, 0.61%
Maad Rayan Publishing Company
1 публикация, 0.61%
Tsinghua University Press
1 публикация, 0.61%
Korean Society of Cancer Prevention
1 публикация, 0.61%
Taylor & Francis
1 публикация, 0.61%
Federation of American Societies for Experimental Biology (FASEB)
1 публикация, 0.61%
Irkutsk National Research Technical University
1 публикация, 0.61%
5
10
15
20
25
30
35
40
45
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
 Войти с ORCID
Метрики
165
Поделиться
Цитировать
ГОСТ |
Цитировать
Król S. K. et al. Comprehensive Review on Betulin as a Potent Anticancer Agent // BioMed Research International. 2015. Vol. 2015. pp. 1-11.
ГОСТ со всеми авторами (до 50) Скопировать
Król S. K., Kiełbus M., Rivero-Muller A., Stepulak A. Comprehensive Review on Betulin as a Potent Anticancer Agent // BioMed Research International. 2015. Vol. 2015. pp. 1-11.
RIS |
Цитировать
TY - JOUR
DO - 10.1155/2015/584189
UR - https://doi.org/10.1155/2015/584189
TI - Comprehensive Review on Betulin as a Potent Anticancer Agent
T2 - BioMed Research International
AU - Król, Sylwia Katarzyna
AU - Kiełbus, Michał
AU - Rivero-Muller, Adolfo
AU - Stepulak, Andrzej
PY - 2015
DA - 2015/03/19
PB - Hindawi Limited
SP - 1-11
VL - 2015
PMID - 25866796
SN - 2314-6133
SN - 2314-6141
ER -
BibTex
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2015_Król,
author = {Sylwia Katarzyna Król and Michał Kiełbus and Adolfo Rivero-Muller and Andrzej Stepulak},
title = {Comprehensive Review on Betulin as a Potent Anticancer Agent},
journal = {BioMed Research International},
year = {2015},
volume = {2015},
publisher = {Hindawi Limited},
month = {mar},
url = {https://doi.org/10.1155/2015/584189},
pages = {1--11},
doi = {10.1155/2015/584189}
}
Ошибка в публикации?